Literature DB >> 2362400

Renal iron handling in the nephrotic syndrome.

A C Alfrey1, W S Hammond.   

Abstract

Renal iron handling was characterized in three experimental models of the nephrotic syndrome: puromycin aminonucleoside, adriamycin and nephrotoxic serum. In adriamycin-induced nephrotic syndrome, which has previously been shown to result from alterations in pore size of the filtration barrier, the transferrin leak was most severe with a fractional clearance of 25%, a value identical to albumin. In contrast, in puromycin nephrotic syndrome and nephrotoxic serum nephritis the fractional clearance of transferrin was never greater than 2% and consistently less than the fractional clearance of albumin. The fact that iron/transferrin ratios in urine and serum were frequently different, sometimes higher other times lower, documents that iron and transferrin can be dissociated in tubule fluid and handled differently in regards to tubule uptake. Kidney iron concentration is also increased in both immunological and non-immunological forms of nephrotic syndrome. In the proximal tubule iron is present largely on the luminal aspect of the cell. In contrast, the major deposition of iron occurs in the lysosomes of the distal tubule cells. Kidney iron concentration does not correlate with tubule fluid iron content but can be prevented from increasing by systemic iron and/or transferrin depletion. This suggests that iron enters the distal tubule cells with transferrin via its receptors from the basolateral side of the distal tubule cells. In association with the increase tubule fluid and kidney iron, there is a marked reduction in kidney selenium and copper content. It is concluded that urinary iron and transferrin losses can vary greatly in different types of experimental renal diseases, and that iron and transferrin can be dissociated in the tubule fluid.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2362400     DOI: 10.1038/ki.1990.130

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  Transport of iron chelators and chelates across MDCK cell monolayers: implications for iron excretion during chelation therapy.

Authors:  Xi-Ping Huang; Jake J Thiessen; Michael Spino; Douglas M Templeton
Journal:  Int J Hematol       Date:  2010-03-09       Impact factor: 2.490

2.  In vivo characterization of renal iron transport in the anaesthetized rat.

Authors:  M Wareing; C J Ferguson; R Green; D Riccardi; C P Smith
Journal:  J Physiol       Date:  2000-04-15       Impact factor: 5.182

3.  Renal clearance of endogenous erythropoietin in patients with proteinuria.

Authors:  M Nowicki; F Kokot; M Kokot; A Bar; J Duława
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

Review 4.  Iron metabolism in the pathogenesis of iron-induced kidney injury.

Authors:  A M F Martines; R Masereeuw; H Tjalsma; J G Hoenderop; J F M Wetzels; D W Swinkels
Journal:  Nat Rev Nephrol       Date:  2013-05-14       Impact factor: 28.314

5.  Nifedipine Increases Iron Content in WKPT-0293 Cl.2 Cells via Up-Regulating Iron Influx Proteins.

Authors:  Shuang-Shuang Yu; Li-Rong Jiang; Yan Ling; Zhong-Ming Qian; Yu-Fu Zhou; Juan Li; Ya Ke
Journal:  Front Pharmacol       Date:  2017-02-13       Impact factor: 5.810

6.  Impact of Intravenous Iron on Oxidative Stress and Mitochondrial Function in Experimental Chronic Kidney Disease.

Authors:  Faisal Nuhu; Anne-Marie Seymour; Sunil Bhandari
Journal:  Antioxidants (Basel)       Date:  2019-10-21

7.  Kidney tubule iron loading in experimental focal segmental glomerulosclerosis.

Authors:  Dorine W Swinkels; Bart Smeets; Rachel P L van Swelm; Sanne Beurskens; Henry Dijkman; Erwin T G Wiegerinck; Rian Roelofs; Frank Thévenod; Johan van der Vlag; Jack F M Wetzels
Journal:  Sci Rep       Date:  2022-01-24       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.